½ÃÀ庸°í¼­
»óǰÄÚµå
1764917

ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ¿¹Ãø(-2031³â) - Áö¿ªº° ºÐ¼®(Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°)

North America Lithotripsy Market Forecast to 2031 - Regional Analysis - by Product Type, Application, and End User

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 134 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀåÀº 2023³â¿¡ 6¾ï 1,284¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2031³â¿¡´Â 10¾ï 3,950¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023³âºÎÅÍ 2031³â±îÁö 6.8%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºñħ½ÀÀû °á¼®ÆÄ¼â¼ú¿¡ ´ëÇÑ ÀÇ·áºñ ȯ±Þ/º¸Çè Àû¿ëÀ¸·Î ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ¼ºÀå ÃËÁø

¼ö¼úÀº ½ÅÀå °á¼®À¸·Î °íÅë¹Þ´Â ȯÀÚ¸¦ À§ÇÑ ÀüÅëÀûÀÎ Ä¡·á ¿É¼ÇÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼ú¿¡´Â ½ÅÀå ÀýÁ¦¼ú°ú ¿äµµ ³»½Ã°æ Ä¡·á°¡ Æ÷ÇԵ˴ϴÙ. ±×·¯³ª ÃÖ±Ù ¸î ³â µ¿¾È »óºÎ ¿ä·Î °á¼® Ä¡·á¸¦ À§ÇÑ ºñħ½ÀÀû °á¼® ÆÄ¼â¼ú°ú °°Àº »õ·Î¿î Á¢±Ù¹ýÀÌ °³¹ßµÇ¾ú½À´Ï´Ù. ȯÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ºñħ½ÀÀû Ä¡·á¹ýÀ¸·Î Á¡Â÷ ÀüȯµÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ ¸ÞµðÄÉ¾î ¹× ¸ÞµðÄÉÀÌµå ¼­ºñ½º ¼¾ÅÍ¿¡ µû¸£¸é, ±âÁ¸ °á¼®ÆÄ¼â¼ú°ú ºñħ½ÀÀû °á¼®ÆÄ¼â¼úÀº ¸ðµÎ ÀǷẸÇèÀÌ Àû¿ëµË´Ï´Ù. ºñħ½ÀÀû °á¼®ÆÄ¼â¼ú¿¡´Â ü¿ÜÃæ°ÝÆÄ¼â¼®¼ú, °æÇÇÀû °á¼®ÆÄ¼â¼ú, °æ¿äµµÀû ¿ä°ü°æÇÏ °á¼®ÆÄ¼â¼úÀÌ Æ÷ÇԵ˴ϴÙ. µû¶ó¼­ ºñħ½ÀÀû °á¼®ÆÄ¼â¼ú¿¡ ´ëÇÑ ÀǷẸÇè Àû¿ë/ȯ±ÞÀº Àü¹® °á¼®ÆÄ¼â¼¾ÅÍ ¹× º´¿øÀ» ã´Â ȯÀÚ Áõ°¡·Î À̾îÁ® ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå °³¿ä

ºÏ¹ÌÀÇ °á¼® ºÐ¼â¼ú ½ÃÀåÀÇ ¼ºÀåÀº °á¼® ºÐ¼â¼ú °³¹ß¿¡ »ç¿ëµÇ´Â ±â¼úÀÇ ¹ßÀü, ½ÅÀå °á¼® »ç·ÊÀÇ ±ÞÁõ, °íǰÁú ÀÇ·á ¹× È¯ÀÚ ¾ÈÀüÀ» À§ÇÑ ½Å¼ÓÇÑ Á¦Ç° ½ÂÀο¡ ±âÀÎÇÕ´Ï´Ù. ¾Õ¼­ ¾ð±ÞÇÑ ¿äÀεéÀº 2021-2031³â ºÏ¹Ì ½ÃÀå¿¡¼­ °á¼® ÆÄ¼â¼úÀÇ ¿µÇâ·Â ÀÖ´Â ¼ºÀåÀÇ ¿øÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ´ëÇѺñ´¢±â°úÇÐȸ º¸°í¼­¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ½ÅÀå °á¼®ÀÇ À¯º´·üÀÌ »ó´çÈ÷ ³ôÀ¸¸ç, BDÀÇ À¥»çÀÌÆ®¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ¿¬°£ 11¸í Áß 1¸íÀÌ ½ÅÀå °á¼®À» ¾Î°í ÀÖÀ¸¸ç, ÀÌ´Â »ó´çÇÑ ÀÇ·á ºÎ´ã°ú °í°¡ÀÇ Ä¡·áºñ¸¦ À¯¹ßÇϰí ÀÖ½À´Ï´Ù. Áø´Ü¿¡¼­ Ä¡·á±îÁö °É¸®´Â ½Ã°£Àº ¾à 18ÀÏÀ̸ç, ȯÀÚÀÇ ¾à 50%°¡ °á¼® Á¦°Å¼ú(´ëºÎºÐ ü¿ÜÃæ°ÝÆÄ¼â¼®¼ú(ESWL)À» ½ÃÇàÇÏ´Â °ÍÀÌ ¹Ù¶÷Á÷ÇÏ´Ù)À» ±ÇÀå¹Þ½À´Ï´Ù. ¶ÇÇÑ, ¹Ì±¹¿¡¼­ °¡Àå ÀϹÝÀûÀ¸·Î ±ÇÀåµÇ´Â ºñħ½ÀÀû ½Ã¼úÀº °á¼®ÆÄ¼â¼úÀÔ´Ï´Ù.

ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ¼öÀÍ ¹× 2031³â±îÁöÀÇ ¿¹Ãø(±Ý¾×)

ºÏ¹Ì °á¼® ÆÄ¼â¼ú ½ÃÀå ¼¼ºÐÈ­

ºÏ¹Ì °á¼® ºÐ¼â±â ½ÃÀåÀº Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ ¹× ±¹°¡º°·Î ºÐ·ùµË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀåÀº ü¿ÜÃæ°ÝÆÄ °á¼®ÆÄ¼â¼ú, ü³» °á¼®ÆÄ¼â¼ú, ¿ä°ü°æÀ¸·Î ºÐ·ùµË´Ï´Ù. ü¿ÜÃæ°ÝÆÄ °á¼®ÆÄ¼â¼ú ºÎ¹®Àº 2023³â ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå Á¡À¯À²¿¡¼­ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇß½À´Ï´Ù.

¿ëµµº°·Î ºÏ¹Ì °á¼® Á¦°Å¼ú ½ÃÀåÀº ½ÅÀå °á¼®, ¿ä°ü °á¼®, ÃéÀå °á¼®, ´ã°ü °á¼®, ¹æ±¤ °á¼®À¸·Î ±¸ºÐµÇ¸ç, 2023³â ºÏ¹Ì °á¼® Á¦°Å¼ú ½ÃÀå Á¡À¯À²Àº ½ÅÀå °á¼® ºÎ¹®ÀÌ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀåÀº º´¿ø, Àü¹® Ŭ¸®´Ð, ±âŸ·Î ±¸ºÐµÇ¸ç, 2023³â ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå Á¡À¯À²Àº º´¿ø ºÎ¹®ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

±¹°¡º°·Î ºÏ¹Ì °á¼® Á¦°Å¼ú ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ºÐ·ùµË´Ï´Ù. ¹Ì±¹ ºÎ¹®Àº 2023³â ºÏ¹Ì °á¼® Á¦°Å¼ú ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Becton Dickinson and Co,Boston Scientific Corp,Cook Medical Holdings LLC,DirexGroup,Dornier MedTech,Edap Tms SA,ELMED Medical Systems,EMS Electro Medical Systems SA(EMS+),Karl Storz SE &Co KG,NOVAmedtk,Olympus Corp,Potent MedicalÀº ºÏ¹Ì ¼â¼®¼ú ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®

Á¦3Àå ºÐ¼® ¹æ¹ý

  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç
    • °¡¼³ Ã¥Á¤
    • °Å½Ã°æÁ¦ ¿äÀÎ ºÐ¼®
    • ±âÃÊ ¼öÄ¡ °³¹ß
    • µ¥ÀÌÅÍ »ï°¢Ãø·®
    • ±¹°¡ ·¹º§ µ¥ÀÌÅÍ

Á¦4Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ÇâÈÄ µ¿Çâ
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇâ

Á¦5Àå °á¼®ÆÄ¼â¼ú½ÃÀå : ºÏ¹Ì ½ÃÀå ºÐ¼®

  • °á¼®ÆÄ¼â¼ú ½ÃÀå ¸ÅÃâ(2021-2031³â)

Á¦6Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ºÐ¼® : À¯Çüº°

  • ü¿Ü Ãæ°ÝÆÄ °á¼®ÆÄ¼â¼ú
  • ü³» Ãæ°ÝÆÄ °á¼®ÆÄ¼â¼ú
  • ¿ä°ü°æ

Á¦7Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ºÐ¼® : ü¿Ü Ãæ°ÝÆÄ °á¼®ÆÄ¼â¼ú º°¡¤ÀûÀÀÁõº°

  • PCNL
  • ±âŸ

Á¦8Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ºÐ¼® : PCNL Àåºñº°, À¯Çüº°

  • ·¹ÀÌÀú
  • ÃÊÀ½ÆÄ ¹× ÄÞºñ³×À̼Ç

Á¦9Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ºÐ¼® : PCNL Àåºñº°, ·¹ÀÌÀú ºÎǰº°

  • ÀÚº» ¼³ºñ
  • ¼Ò¸ðǰ

Á¦10Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ºÐ¼® : PCNL Àåºñº°, ÃÊÀ½ÆÄ¡¤ÄÞºñ³×ÀÌ¼Ç ºÎǰº°

  • ÀÚº» ¼³ºñ
  • ¼Ò¸ðǰ

Á¦11Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ºÐ¼® : ¿ä°ü°æ ±â¼úº°

  • ¿ä°ü°æ ·¹ÀÌÀú
  • ¿ä°ü°æ °ø¾Ð źµµ °Ë»ç

Á¦12Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ºÐ¼® : ¿ä°ü°æ ·¹ÀÌÀú ¹ýº°, ºÎǰº°

  • ÀÚº» ¼³ºñ
  • ¼¶À¯

Á¦13Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ºÐ¼® : ¿ä°ü°æ ·¹ÀÌÀú ¹ýº°, À¯Çüº°

  • Æ«·ý
  • °íÃâ·Â Ȧ¹Å
  • ÀúÃâ·Â
  • ±âŸ ·¹ÀÌÀú

Á¦14Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ºÐ¼® : ¿ä°ü°æ °ø¾Ð źµµ °Ë»çº°, ºÎǰº°

  • ÀÚº» ¼³ºñ
  • ¼Ò¸ðǰ

Á¦15Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ½ÅÀå°á¼®
  • ¿ä°ü °á¼®
  • ÃéÀå °á¼®
  • ´ã°ü °á¼®
  • ¹æ±¤ °á¼®

Á¦16Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ºÐ¼® : ¹æ±¤ °á¼®º°, ¹æ¹ý À¯Çüº°

  • ·¹ÀÌÀú
  • ±â°è½Ä
  • °ø¾Ð½Ä/źµµ½Ä
  • ÃÊÀ½ÆÄ½Ä

Á¦17Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • Àü¹® Ŭ¸®´Ð ¹× ¼¾ÅÍ
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦18Àå ºÏ¹ÌÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå : ±¹°¡º° ºÐ¼®

    • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ

Á¦19Àå °æÀï ±¸µµ

  • ¼¼°èÀÇ °á¼®ÆÄ¼â¼ú ½ÃÀå ¼ºÀå Àü·«
  • À¯±âÀû °³¹ß
  • ¹«±âÀû °³¹ß

Á¦20Àå ±â¾÷ °³¿ä

  • Edap Tms SA
  • Becton Dickinson and Co
  • Olympus Corp
  • Cook Medical Holdings LLC
  • Boston Scientific Corp
  • Karl Storz SE & Co KG
  • DirexGroup
  • Dornier MedTech
  • ELMED Medical Systems
  • EMS Electro Medical Systems SA(EMS+)
  • NOVAmedtk
  • Potent Medical

Á¦21Àå ºÎ·Ï

LSH

The North America lithotripsy market was valued at US$ 612.84 million in 2023 and is expected to reach US$ 1,039.50 million by 2031; it is estimated to register a CAGR of 6.8% from 2023 to 2031.

Medical Reimbursement/Coverage for Noninvasive Lithotripsy Procedure Fuels North America Lithotripsy Market

Surgery is a traditional treatment option for patients suffering from kidney stones. These surgeries include nephrectomy and endoscopic treatment of the urethra. However, in the past few years, several new approaches have been developed such as noninvasive lithotripsy techniques for the treatment of upper urinary tract kidney stones. Patients are gradually shifting toward noninvasive procedures owing to increased awareness. According to the US Centers for Medicare & Medicaid Services, all traditional and noninvasive lithotripsy techniques are medically insured/reimbursed. These noninvasive lithotripsy techniques include extracorporeal shock wave lithotripsy, percutaneous lithotripsy, and transurethral ureteroscopic lithotripsy. Therefore, medical coverage/reimbursement for noninvasive lithotripsy procedures leads to an increase in patient visits to specialized lithotripsy centers and hospitals, which fuels the market growth.

North America Lithotripsy Market Overview

The lithotripsy market growth in North America is attributed to advancements in the technologies used in the development of lithotripsy devices, surging kidney stone cases, and fast product approvals for high-quality healthcare and patient safety. The aforementioned factors are responsible for influential growth of lithotripsy in North America regional market during 2021-2031. According to the Korean Urological Association report, the prevalence of nephrolithiasis (kidney stone) is significantly high in the US. The BD company website reveals that kidney stones affect 1 in 11 people in the US annually, causing a considerable healthcare burden and high cost of treatment. The length of time from diagnosis to treatment takes approximately 18 days, with ~50% of the patients recommended to perform lithotripsy procedures [the majority are treated with extracorporeal shockwave lithotripsy (ESWL)] by physicians. Additionally, the most commonly recommended noninvasive procedure in the US is lithotripsy.

North America Lithotripsy Market Revenue and Forecast to 2031 (US$ Million)

North America Lithotripsy Market Segmentation

The North America lithotripsy market is categorized into product type, application, end user, and country.

By product type, the North America lithotripsy market is segmented into extracorporeal shock wave lithotripsy devices, intracorporeal lithotripsy devices, and ureteroscopic. The extracorporeal shock wave lithotripsy devices segment held the largest share of the North America lithotripsy market share in 2023.

In term of application, the North America lithotripsy market is segmented into kidney stones, ureteral stones, pancreatic stones, bile duct stones, and bladder stones. The kidney stones segment held the largest share of the North America lithotripsy market share in 2023.

Based on end user, the North America lithotripsy market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the North America lithotripsy market share in 2023.

Based on country, the North America lithotripsy market is segmented into the US, Canada, and Mexico. The US segment held the largest share of North America lithotripsy market in 2023.

Becton Dickinson and Co, Boston Scientific Corp, Cook Medical Holdings LLC, DirexGroup, Dornier MedTech, Edap Tms SA, ELMED Medical Systems, EMS Electro Medical Systems SA (EMS+), Karl Storz SE & Co KG, NOVAmedtk, Olympus Corp, and Potent Medical are some of the leading companies operating in the North America lithotripsy market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Lithotripsy Market - Key Market Dynamics

  • 4.1 North America Lithotripsy Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Medical Reimbursement/Coverage for Noninvasive Lithotripsy Procedure
    • 4.2.2 Launch of Innovative Lithotripsy Devices
  • 4.3 Market Restraints
    • 4.3.1 Rise in Product Recalls by FDA
  • 4.4 Market Opportunities
    • 4.4.1 Rise in Mobile Lithotripsy Services
  • 4.5 Future Trends
    • 4.5.1 Preference for Lithotripsy Technique in Coronary Lesion Treatment
  • 4.6 Impact of Drivers and Restraints:

5. Lithotripsy Market -North America Market Analysis

  • 5.1 North America Lithotripsy Market Revenue (US$ Million), 2021-2031

6. North America Lithotripsy Market Analysis - by Type

  • 6.1 Extracorporeal Shock Wave Lithotripsy Devices
    • 6.1.1 Overview
    • 6.1.2 Extracorporeal Shock Wave Lithotripsy Devices: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Intracorporeal Lithotripsy Devices
    • 6.2.1 Overview
    • 6.2.2 Intracorporeal Lithotripsy Devices: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Ureteroscopic
    • 6.3.1 Overview
    • 6.3.2 Ureteroscopic: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Lithotripsy Market Analysis - by Intracorporeal Lithotripsy Devices by Indications

  • 7.1 PCNL
    • 7.1.1 PCNL: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Others
    • 7.2.1 Others: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Lithotripsy Market Analysis - by PCNL Devices Type

  • 8.1 Laser
    • 8.1.1 Laser: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Ultrasonic and Combination
    • 8.2.1 Ultrasonic and Combination: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Lithotripsy Market Analysis - by PCNL Devices by Laser Component

  • 9.1 Capital
    • 9.1.1 Capital: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Consumables
    • 9.2.1 Consumables: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Lithotripsy Market Analysis - by PCNL Devices by Ultrasonic and Combination Component

  • 10.1 Capital
    • 10.1.1 Capital: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Consumables
    • 10.2.1 Consumables: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)

11. North America Lithotripsy Market Analysis - by Ureteroscopy Technique

  • 11.1 Ureteroscopy Laser
    • 11.1.1 Ureteroscopy Laser: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Ureteroscopy Pneumatic Ballistic
    • 11.2.1 Ureteroscopy Pneumatic Ballistic: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)

12. North America Lithotripsy Market Analysis - by Ureteroscopy Laser by Component

  • 12.1 Capital
    • 12.1.1 Capital: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 12.2 Fibre
    • 12.2.1 Fibre: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)

13. North America Lithotripsy Market Analysis - by Ureteroscopy Laser by Type

  • 13.1 Thulium
    • 13.1.1 Thulium: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 13.2 High power Holmium
    • 13.2.1 High power Holmium: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 13.3 Low Power
    • 13.3.1 Low Power: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 13.4 Other Laser
    • 13.4.1 Other Laser: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)

14. North America Lithotripsy Market Analysis - by Ureteroscopy Pneumatic Ballistic by Component

  • 14.1 Capital
    • 14.1.1 Capital: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 14.2 Consumables
    • 14.2.1 Consumables: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)

15. North America Lithotripsy Market Analysis - by Application

  • 15.1 Kidney Stones
    • 15.1.1 Overview
    • 15.1.2 Kidney Stones: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 15.2 Ureteral Stones
    • 15.2.1 Overview
    • 15.2.2 Ureteral Stones: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 15.3 Pancreatic Stones
    • 15.3.1 Overview
    • 15.3.2 Pancreatic Stones: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 15.4 Bile Duct Stones
    • 15.4.1 Overview
    • 15.4.2 Bile Duct Stones: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 15.5 Bladder Stones
    • 15.5.1 Overview
    • 15.5.2 Bladder Stones: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)

16. North America Lithotripsy Market Analysis - by Bladder Stones Technique Type

  • 16.1 Laser
    • 16.1.1 Laser: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 16.2 Mechanical
    • 16.2.1 Mechanical: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 16.3 Pneumatic/Ballistic
    • 16.3.1 Pneumatic/Ballistic: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 16.4 Ultrasonic
    • 16.4.1 Ultrasonic: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)

17. North America Lithotripsy Market Analysis - by End-user

  • 17.1 Hospitals
    • 17.1.1 Overview
    • 17.1.2 Hospitals: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 17.2 Specialty Clinics and Centres
    • 17.2.1 Overview
    • 17.2.2 Specialty Clinics and Centres: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
  • 17.3 Other End Users
    • 17.3.1 Overview
    • 17.3.2 Other End Users: North America Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)

18. North America Lithotripsy Market - Country Analysis

  • 18.1 North America Lithotripsy Market Overview
    • 18.1.1 North America Lithotripsy Market, by Key Countries- Revenue(2023 ) US$ Million
    • 18.1.2 North America: Lithotripsy Market - Revenue and Forecast Analysis - by Country
      • 18.1.2.1 United States: Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
        • 18.1.2.1.1 United States: Lithotripsy Market Breakdown, by Type
        • 18.1.2.1.2 United States: Lithotripsy Market Breakdown, by Intracorporeal Lithotripsy Devices
        • 18.1.2.1.3 United States: Lithotripsy Market Breakdown, by Intracorporeal Lithotripsy Devices by Indications
        • 18.1.2.1.4 United States: Lithotripsy Market Breakdown, by PCNL Devices Type
        • 18.1.2.1.5 United States: Lithotripsy Market Breakdown, by PCNL Devices by Laser Component
        • 18.1.2.1.6 United States: Lithotripsy Market Breakdown, by PCNL Devices by Ultrasonic And Combination Component
        • 18.1.2.1.7 United States: Lithotripsy Market Breakdown, by Ureteroscopy Technique
        • 18.1.2.1.8 United States: Lithotripsy Market Breakdown, by Ureteroscopy Laser by Component
        • 18.1.2.1.9 United States: Lithotripsy Market Breakdown, by Ureteroscopy Laser by Type
        • 18.1.2.1.10 United States: Lithotripsy Market Breakdown, by Ureteroscopy Pneumatic Ballistic by Component
        • 18.1.2.1.11 United States: Lithotripsy Market Breakdown, by Application
        • 18.1.2.1.12 United States: Lithotripsy Market Breakdown, by Bladder Stones Technique Type
        • 18.1.2.1.13 United States: Lithotripsy Market Breakdown, by End-user
      • 18.1.2.2 Canada: Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
        • 18.1.2.2.1 Canada: Lithotripsy Market Breakdown, by Type
        • 18.1.2.2.2 Canada: Lithotripsy Market Breakdown, by Intracorporeal Lithotripsy Devices
        • 18.1.2.2.3 Canada: Lithotripsy Market Breakdown, by Intracorporeal Lithotripsy Devices by Indications
        • 18.1.2.2.4 Canada: Lithotripsy Market Breakdown, by PCNL Devices Type
        • 18.1.2.2.5 Canada: Lithotripsy Market Breakdown, by PCNL Devices by Laser Component
        • 18.1.2.2.6 Canada: Lithotripsy Market Breakdown, by PCNL Devices by Ultrasonic And Combination Component
        • 18.1.2.2.7 Canada: Lithotripsy Market Breakdown, by Ureteroscopy Technique
        • 18.1.2.2.8 Canada: Lithotripsy Market Breakdown, by Ureteroscopy Laser by Component
        • 18.1.2.2.9 Canada: Lithotripsy Market Breakdown, by Ureteroscopy Laser by Type
        • 18.1.2.2.10 Canada: Lithotripsy Market Breakdown, by Ureteroscopy Pneumatic Ballistic by Component
        • 18.1.2.2.11 Canada: Lithotripsy Market Breakdown, by Application
        • 18.1.2.2.12 Canada: Lithotripsy Market Breakdown, by Bladder Stones Technique Type
        • 18.1.2.2.13 Canada: Lithotripsy Market Breakdown, by End-user
      • 18.1.2.3 Mexico: Lithotripsy Market - Revenue and Forecast to 2031 (US$ Million)
        • 18.1.2.3.1 Mexico: Lithotripsy Market Breakdown, by Type
        • 18.1.2.3.2 Mexico: Lithotripsy Market Breakdown, by Intracorporeal Lithotripsy Devices
        • 18.1.2.3.3 Mexico: Lithotripsy Market Breakdown, by Intracorporeal Lithotripsy Devices by Indications
        • 18.1.2.3.4 Mexico: Lithotripsy Market Breakdown, by PCNL Devices Type
        • 18.1.2.3.5 Mexico: Lithotripsy Market Breakdown, by PCNL Devices by Laser Component
        • 18.1.2.3.6 Mexico: Lithotripsy Market Breakdown, by PCNL Devices by Ultrasonic And Combination Component
        • 18.1.2.3.7 Mexico: Lithotripsy Market Breakdown, by Ureteroscopy Technique
        • 18.1.2.3.8 Mexico: Lithotripsy Market Breakdown, by Ureteroscopy Laser by Component
        • 18.1.2.3.9 Mexico: Lithotripsy Market Breakdown, by Ureteroscopy Laser by Type
        • 18.1.2.3.10 Mexico: Lithotripsy Market Breakdown, by Ureteroscopy Pneumatic Ballistic by Component
        • 18.1.2.3.11 Mexico: Lithotripsy Market Breakdown, by Application
        • 18.1.2.3.12 Mexico: Lithotripsy Market Breakdown, by Bladder Stones Technique Type
        • 18.1.2.3.13 Mexico: Lithotripsy Market Breakdown, by End-user

19. Competitive Landscape

  • 19.1 Overview
  • 19.2 Growth Strategies in the Global Lithotripsy Market
  • 19.3 Organic Developments
    • 19.3.1 Overview
  • 19.4 Inorganic Developments
    • 19.4.1 Overview

20. Company Profiles

  • 20.1 Edap Tms SA
    • 20.1.1 Key Facts
    • 20.1.2 Business Description
    • 20.1.3 Products and Services
    • 20.1.4 Financial Overview
    • 20.1.5 SWOT Analysis
    • 20.1.6 Key Developments
  • 20.2 Becton Dickinson and Co
    • 20.2.1 Key Facts
    • 20.2.2 Business Description
    • 20.2.3 Products and Services
    • 20.2.4 Financial Overview
    • 20.2.5 SWOT Analysis
    • 20.2.6 Key Developments
  • 20.3 Olympus Corp
    • 20.3.1 Key Facts
    • 20.3.2 Business Description
    • 20.3.3 Products and Services
    • 20.3.4 Financial Overview
    • 20.3.5 SWOT Analysis
    • 20.3.6 Key Developments
  • 20.4 Cook Medical Holdings LLC
    • 20.4.1 Key Facts
    • 20.4.2 Business Description
    • 20.4.3 Products and Services
    • 20.4.4 Financial Overview
    • 20.4.5 SWOT Analysis
    • 20.4.6 Key Developments
  • 20.5 Boston Scientific Corp
    • 20.5.1 Key Facts
    • 20.5.2 Business Description
    • 20.5.3 Products and Services
    • 20.5.4 Financial Overview
    • 20.5.5 SWOT Analysis
    • 20.5.6 Key Developments
  • 20.6 Karl Storz SE & Co KG
    • 20.6.1 Key Facts
    • 20.6.2 Business Description
    • 20.6.3 Products and Services
    • 20.6.4 Financial Overview
    • 20.6.5 SWOT Analysis
    • 20.6.6 Key Developments
  • 20.7 DirexGroup
    • 20.7.1 Key Facts
    • 20.7.2 Business Description
    • 20.7.3 Products and Services
    • 20.7.4 Financial Overview
    • 20.7.5 SWOT Analysis
    • 20.7.6 Key Developments
  • 20.8 Dornier MedTech
    • 20.8.1 Key Facts
    • 20.8.2 Business Description
    • 20.8.3 Products and Services
    • 20.8.4 Financial Overview
    • 20.8.5 SWOT Analysis
    • 20.8.6 Key Developments
  • 20.9 ELMED Medical Systems
    • 20.9.1 Key Facts
    • 20.9.2 Business Description
    • 20.9.3 Products and Services
    • 20.9.4 Financial Overview
    • 20.9.5 SWOT Analysis
    • 20.9.6 Key Developments
  • 20.10 EMS Electro Medical Systems SA (EMS+)
    • 20.10.1 Key Facts
    • 20.10.2 Business Description
    • 20.10.3 Products and Services
    • 20.10.4 Financial Overview
    • 20.10.5 SWOT Analysis
    • 20.10.6 Key Developments
  • 20.11 NOVAmedtk
    • 20.11.1 Key Facts
    • 20.11.2 Business Description
    • 20.11.3 Products and Services
    • 20.11.4 Financial Overview
    • 20.11.5 SWOT Analysis
    • 20.11.6 Key Developments
  • 20.12 Potent Medical
    • 20.12.1 Key Facts
    • 20.12.2 Business Description
    • 20.12.3 Products and Services
    • 20.12.4 Financial Overview
    • 20.12.5 SWOT Analysis
    • 20.12.6 Key Developments

21. Appendix

  • 21.1 About The Insight Partners
  • 21.2 Glossary of Terms
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦